{"id":"W4409523417","doi":"10.1093/eurjpc/zwaf214","title":"Efficacy and safety of inclisiran based on background lipid-lowering treatment","year":2025,"lang":"en","type":"article","venue":"European Journal of Preventive Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"Novartis Pharma; Esperion Therapeutics; Amgen; Singulex; Daiichi Sankyo Europe; Sanofi; Kowa Company; Medicines Company; Novo Nordisk; Genentech; Bristol-Myers Squibb; AstraZeneca; Pfizer","keywords":"Medicine; Intensive care medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001761457,0.0001447152,0.0007865881,0.0002035045,0.00005304816,0.000005639751,0.00008004627,0.0000361372,0.00001485608],"category_scores_gemma":[0.0001504246,0.0001042614,0.0004747176,0.0001231049,0.000100914,0.00002795939,0.00004314384,0.0002007034,0.000003149308],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001080228,"about_ca_system_score_gemma":0.0001564893,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000353297,"about_ca_topic_score_gemma":3.775208e-7,"domain_scores_codex":[0.9979547,0.00101294,0.000530751,0.0001751052,0.0001662392,0.0001603185],"domain_scores_gemma":[0.9990458,0.0001490441,0.00022809,0.0002978761,0.0001709418,0.0001082403],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01225106,0.0007208752,0.01802138,0.0006026982,0.006946976,0.002597022,0.000490237,0.001783464,0.008150692,0.0004809785,0.0008242056,0.9471304],"study_design_scores_gemma":[0.02318662,0.01023623,0.8825517,0.001677042,0.001280167,0.0005530187,0.0002147594,0.00003271206,0.002516415,0.0000294077,0.07754366,0.000178232],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9488145,0.003219713,0.01559468,0.000410935,0.0005269316,0.0004760314,0.000008352898,0.00001002563,0.0309389],"genre_scores_gemma":[0.9978987,0.0007277649,0.0005162256,0.0001889817,0.0004291469,0.000001195036,0.000003462798,0.00001653866,0.0002179611],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9469522,"threshold_uncertainty_score":0.4251657,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02082736051751484,"score_gpt":0.2912412490454311,"score_spread":0.2704138885279163,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}